Wutah dodolan YoY sajrone 12 wulan kepungkur: immixbio.com (IMMX)

Logo perusahaan publik immixbio.com (IMMX)

The development of T-cell therapies to combat solid tumors laid the foundation for growth, and the comparable year-over-year sales growth over 12 months on GURU.Markets reflects this peak. Subsequently, Immix Biopharma, Inc. (IMMX) established the IMX-110 ecosystem with hospital hubs, and the parameter stabilized at 0.00. Currently, Immix Biopharma, Inc. (IMMX) is implementing cultivation automation to eliminate defects in the production of CAR-T therapies.

Wutah pendapatan YoY sajrone 12 wulan kepungkur Immix (IMMX): kanggo periode 11.02.2024 - 18.11.2026

Immix Biopharma, Inc. (IMMX) - rincian metrik lan laporan keuangan

Ringkesan analitik perusahaan:Immix Biopharma, Inc.
Sampel barang Immix

This indicator measures revenue dynamics over a rolling twelve-month period, capturing the daily growth rate of income. Analyzing this metric helps avoid purchasing overvalued assets by identifying the gap between market price and actual operational growth. By examining the trailing twelve months (TTM) growth of operating sales revenue, an investor can gauge the effectiveness of commercializing developments. For Immix Biopharma, Inc. (IMMX), such dynamics confirm the return on retaining an elite staff of immunologists. The cohesion of the scientific team converts directly into the stability of the company's financial performance.

Pesaing Immix Biopharma, Inc. (IMMX)

Wutah dodolan YoY (TTM) NantKwest IBRX|IMCR - Wutah dodolan YoY sajrone rolas wulan kepungkur|JANX (januxrx.com) - Wutah dodolan YoY sajrone 12 wulan kepungkur|Arcus Corp (RCUS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taun lumaku Zymeworks Corp (ZYME)|Wutah pendapatan YoY sajrone 12 wulan kepungkur TNGX|IOVA - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur IMTX (Immatics Corp)|Owah-owahan pendapatan YoY sajrone 12 wulan kepungkur XNCR|Wutah dodolan YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Dinamika pendapatan YoY sajrone rolas wulan kepungkur REPL|lyell.com - Wutah dodolan YoY (TTM)|Wutah pendapatan taun lumaku Innate Pharma S.A|Pyxis (PYXS) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Compugen Ltd - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|IOBT (iobiotech.com) - Wutah dodolan YoY (TTM)|Wutah dodolan YoY (TTM) Sutro Biopharma Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur MiNK Therapeutics (INKT)|HOWL: Wutah dodolan taun lumaku|alxoncology.com - Wutah pendapatan YoY sajrone 12 wulan kepungkur|CUE - Wutah pendapatan YoY sajrone 12 wulan kepungkur|PDSB - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur Sonnet BioTherapeutics Holdings SONN|MAIA: Wutah dodolan YoY (TTM)|LIMN - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur LVTX|Wutah dodolan YoY sajrone 12 wulan kepungkur NXTC (NextCure)|Wutah dodolan YoY sajrone rolas wulan kepungkur leaptx.com (LPTX)|INTS - Wutah pendapatan taun lumaku|Wutah dodolan YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Theriva Biologics, Inc. (TOVX)|GRTS: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taunan sajrone rolas wulan kepungkur kinetabio.com KA|NEXI (neximmune.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah pendapatan taun lumaku Turnstone Biologics Corporation (TSBX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur VCNX|HARP: Dinamika pendapatan YoY sajrone rolas wulan kepungkur